Directori de persones
Joan Valls Marsal

Joan Valls Marsal

Grau: Doctor/a

28 02
joan.valls(ELIMINAR)@udl.cat

ResearcherID: http://www.researcherid.com/rid/GXM-6532-2022

Grups

Publicacions

  • Barbé F; Sánchez-de-la-Torre A; Abad J; Durán-Cantolla J; Mediano O; Amilibia J; Masdeu MJ; Florés M; Barceló A; de la Peña M; Aldomá A; Worner F; Valls J; Castellà G; Sánchez-de-la-Torre M

    Effect of obstructive sleep apnoea on severity and short-term prognosis of acute coronary syndrome

    EUROPEAN RESPIRATORY JOURNAL 45 419-427. .

    [doi:10.1183/09031936.00071714]

  • Casas-Mendez, LF; Sanchez-de-la-Torre, A; Sanchez-de-la-Torre, M; Abad, J; Duran-Cantolla, J; Mediano, O; Amilibia, J; Masdeu, M; Valls, J; Castella, G; Barbe, F

    Lung Function Impairment Is Not Associated With The Severity Of Acute Coronary Syndrome

    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 191 -. .

  • Santacana M; Maiques O; Valls J; Gatius S; Abó AI; López-García MÁ; Mota A; Reventós J; Moreno-Bueno G; Palacios J; Bartosch C; Dolcet X; Matias-Guiu X

    A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

    HUMAN PATHOLOGY 45 2394-2403. .

    [doi:10.1016/j.humpath.2014.06.031]

  • Bergadà L; Pallares J; Arcidiacono MV; Cardus A; Santacana M; Valls J; Cao G; Fernàndez E; Dolcet X; Dusso AS; Matias-Guiu X

    Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma

    LABORATORY INVESTIGATION 94 608-622. .

    [doi:10.1038/labinvest.2014.57]

  • Sánchez-de-la-Torre M; Barceló A; Piérola J; de la Peña M; Valls J; Barbé F

    Impact of obstructive sleep apnea on the 24-h metabolic hormone profile

    SLEEP MEDICINE 15 625-630. .

    [doi:10.1016/j.sleep.2014.03.007]

  • Vilalta A; Valls J; Porta J; Viñas J

    Evaluation of Spiritual Needs of Patients with Advanced Cancer in a Palliative Care Unit

    JOURNAL OF PALLIATIVE MEDICINE 17 592-600. .

    [doi:10.1089/jpm.2013.0569]

  • Eritja N; Domingo M; Dosil MA; Mirantes C; Santacana M; Valls J; Llombart-Cussac A; Matias-Guiu X; Dolcet X

    Combinatorial Therapy Using Dovitinib and ICI182.780 (Fulvestrant) Blocks Tumoral Activity of Endometrial Cancer Cells

    MOLECULAR CANCER THERAPEUTICS 13 776-787. .

    [doi:10.1158/1535-7163.MCT-13-0794]

  • Maiques O; Santacana M; Valls J; Pallares J; Mirantes C; Gatius S; García Dios DA; Amant F; Pedersen HC; Dolcet X; Matias-Guiu X

    Optimal protocol for PTEN immunostaining; role of analytical and preanalyticat variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues

    HUMAN PATHOLOGY 45 522-532. .

    [doi:10.1016/j.humpath.2013.10.018]

  • Santacana, M; Maiques, O; Valls, J; Gatius, S; Lopez-Garcia, MA; Palacios, J; Dolcet, X; Matias-Guiu, X

    Immunohistochemical Profiling in Assessing Histological Type in Endometrial Carcinoma

    Modern Pathology 27 304-304. .

  • Castelblanco, Esmeralda; Santacana, Maria; Valls, Joan; de Cubas, Aguirre; Cascon, Alberto; Robledo, Mercedes; Matias-Guiu, Xavier

    Usefulness of Negative and Weak-Diffuse Pattern of SDHB Immunostaining in Assessment of SDH Mutations in Paragangliomas and Pheochromocytomas

    ENDOCRINE PATHOLOGY 24 199-205. .

    [doi:10.1007/s12022-013-9269-4]

  • Stresing, V.; Baltziskueta, E.; Rubio, N.; Blanco, J.; Arriba, Ma C.; Valls, J.; Janier, M.; Clezardin, P.; Sanz-Pamplona, R.; Nieva, C.; Marro, M.; Dmitri, P.; Sierra, A.

    Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs

    ONCOGENE 32 724-735. .

    [doi:10.1038/onc.2012.93]

  • Juarez-Escario, A.; Valls, J.; Sole-Senan, X. O.; Conesa, J. A.

    A plant-traits approach to assessing the success of alien weed species in irrigated Mediterranean orchards

    ANNALS OF APPLIED BIOLOGY 162 200-213. .

    [doi:10.1111/aab.12012]

Projectes

  • Effects of intravenous iron therapy with ferric carboxymaltose compared with oral iron therapy in heart failure with preserved ejection fraction and iron deficency/ Efecto sobre la capacidad funcional del tratamiento con hierro intravenoso o hierro oral, comparado con placebo, en pacientes con insuficiencia cardiaca con fracción de eyección del ventrículo izquierdo preservada y anemia ferropénica
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU